Compare Cassava Sciences Inc (FLNA) vs Indonesia Energy Corporation Limited (INDO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Indonesia Energy Corporation Limited — how do they compare? Cassava Sciences Inc trades at $0.83 (market cap $39.40M), while Indonesia Energy Corporation Limited trades at $2.79 (market cap $43.24M). The key difference: Cassava Sciences Inc and Indonesia Energy Corporation Limited are close in size by market cap, and Cassava Sciences Inc is more actively traded (759,018 versus 116,953). Which is the better fit depends on your goals — on Pluang, investors hold Cassava Sciences Inc for 37 Days and Indonesia Energy Corporation Limited for 24 Days on average.
| FLNA | INDO | |
|---|---|---|
Market Cap | $39.40M | $43.24M |
Volume | 759,018 | 116,953 |
Sector | Health | Energy |
52-Week High | $4.64 | $6.74 |
52-Week Low | $0.68 | $2.49 |
Typical Hold Time | 37 Days | 24 Days |
Enterprise Value | -$43.28M | $38.18M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $0.84, up 2.72% today, with a bearish technical signal despite recent earnings beats. The company shows negative profitability metrics with ROE at -55.79% and ROA at -35.34%, though valuation ratios like EV/EBITDA of 1.03 and P/B of 0.62 suggest potential undervaluation. Recent FDA clearance for epilepsy drug trials provides a positive catalyst, but negative cash flow trends and zero revenue remain concerns.
The outlook hinges on clinical trial success and revenue generation. Analyst consensus is bullish with 67% buy ratings, but high execution risk and cash burn require careful monitoring. Near-term catalysts include Phase 2a trial initiation in 2027, while financial sustainability remains the primary challenge for investors.
INDO trades at $2.79, up 0.72% on the day, amid a bearish technical signal. The company reported a net loss of $5.10M on $2.01M revenue for 2025, with negative profit margins. Recent news highlights operational progress, including oil discovery at the K-29 well and participation in investment conferences.
Despite unanimous analyst buy ratings, INDO faces significant financial challenges with persistent losses and negative cash flow from operations. The stock's outlook hinges on successful production scaling from new wells, but execution risks and weak fundamentals present substantial downside potential for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Indonesia Energy Corporation Limited
Indonesia Energy is an oil and gas exploration and production company. It focuses on identifying and developing energy resources in Indonesia, primarily through its Kruh and Citarum blocks.
Read more on INDO →
